Zhong Ji Longevity Science Group to Launch RMB1 Billion Health-Focused M&A FundTip Ranks·Jul 7 at 09:07 AM00767+7.79%
Zhong Ji Longevity Science issues supplemental 2025 annual report disclosure on investment strategy and convertible notes disputePUBT·Jul 6 at 03:32 AM00767+7.79%
Zhong Ji Longevity Science Group Clarifies Investment Strategy and Oversight in 2025 ReportTip Ranks·Jul 2 at 09:09 AM00767+7.79%
Zhong Ji Longevity issues supplemental disclosure on 2025 annual report investment strategyPUBT·Jul 2 at 08:39 AM00767+7.79%
Zhong Ji Longevity Science Delays Circular on Asian Cell Lab AcquisitionTip Ranks·Jun 10 at 10:10 AM00767+7.79%
Zhong Ji Longevity Science Group Further Delays Circular on Cell Lab Stake AcquisitionTip Ranks·Apr 8 at 09:12 AM513120+0.68%00767+7.79%
Zhong Ji Longevity Advances IP Transfer to Clear Key Condition for Stem Cell Unit AcquisitionTip Ranks·Apr 2 at 10:50 AM00767+7.79%513120+0.68%
Zhong Ji Longevity Science Sets Out Board and Committee StructureTip Ranks·Feb 10 at 07:07 AM00767+7.79%
Zhong Ji Longevity Science Delays Circular on 25% Cell Lab Stake DealTip Ranks·Feb 9 at 06:37 AM00767+7.79%
ZHONG JI LS: Yan Yifan resigns as CEO, succeeded by Yan LiAASTOCKS·Oct 19, 2025 at 08:38 PM00767+7.79%
ZHONG JI LS affiliated Zhongli Hainan plans to jointly establish an "International Precision Medicine Center for Oncology" with Hainan BoaoZhitong·Sep 15, 2025 at 04:51 AM00767+7.79%
